Outcomes of cytomegalovirus retinitis-related retinal detachment surgery in acquired immunodeficiency syndrome patients in an Asian population by unknown
Wong et al. BMC Ophthalmology 2014, 14:150
http://www.biomedcentral.com/1471-2415/14/150RESEARCH ARTICLE Open AccessOutcomes of cytomegalovirus retinitis-related
retinal detachment surgery in acquired
immunodeficiency syndrome patients in an
Asian population
John X Wong*, Elizabeth P Wong and Stephen C TeohAbstract
Background: This study reports the surgical outcomes of acquired immunodeficiency syndrome (AIDS) patients
with Cytomegalovirus retinitis (CMVR) -related retinal detachments(RD) in an Asian population.
Methods: Review of CMVR characteristics, surgical outcomes and complications in 19 eyes with CMVR-related RD
that underwent surgery from January 2000 to June 2011.
Results: CMVR was inactive in 73.7% of the eyes at time of surgery. Anatomical success was achieved in 14 eyes.
Seven eyes (36.8%) had improvement of two or more lines in visual acuity (VA) and 8 eyes (42.1%) maintained VA.
Thirteen eyes presented with worse than 6/120 vision, with 30.8% of them achieving ambulatory vision or better.
Five eyes had re-detachments. Median durations from CMVR and immune recovery uveitis (IRU) diagnoses to RD
were 2.7 and 1.0 months respectively.
Conclusions: Surgery for CMVR-related RD is associated with good anatomical outcomes with most eyes maintaining
or having improved vision. CMVR lesion size of <50% retinal area is associated with better outcomes. Eyes with CMVR
and IRU require close monitoring for RD.
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Cytomegalovirus retinitis (CMVR) is the most common
opportunistic eye infection to occur in patients with ac-
quired immune deficiency syndrome (AIDS) worldwide.
It affects up to 22.1% of AIDS patients [1] even in this
era of highly active anti-retroviral therapy (HAART). It
results in visual morbidity from retinitis, or retinal de-
tachment [2] (RD) that occurs in up to 24% of patients
with CMVR [1].
There are limited reports from Asia of surgical out-
comes for CMVR-related RD in AIDS patients. We report
our surgical results of 19 patients with RD secondary to
CMVR. The anatomical and functional outcomes of
these patients were evaluated against patient, ocular and
surgical factors.* Correspondence: john_wong@ttsh.com.sg
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Medical records of HIV patients with CMVR-related RD
who underwent retinal re-attachment surgery at our
centre over 12 years from 1 January 2000 to 1 June 2011
were reviewed. These patients were under the primary
care of infectious disease physicians from the Communic-
able Disease Centre (CDC), Singapore. Ethics approval
was obtained from the National Healthcare Group (NHG)
Domain Specific Review Board (DSRB) (reference A/10/
515), in compliance with the Helsinki Declaration. Retinal
re-attachment surgeries were performed by 6 experienced
vitreo-retinal surgeons from the department.
The demographic characteristics, features of CMVR and
RD were analyzed. Operative techniques for the majority
of cases involved pars plana vitrectomy (20 or 23G), re-
attachment by fluid-air exchange using a drainage retinot-
omy, endolaser, and internal tamponade with silicone oil or
intraocular gas. Circumferential buckling and/or segmentaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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by the surgeon-in-charge. Concurrent phacoemulsification
was performed in eyes with significant cataracts. Prolifera-
tive vitreo-retinopathy (PVR) was classified based on the
1991 modification of the initial classification devised by the
Retina Society [3].
Visual and anatomical outcomes of surgery and com-
plications were assessed at three and six months after
surgery. Visual acuity (VA) was measured using Snellen
charts. For the purpose of data analysis, change of VA
from light perception (PL) to hand movement (HM),
from HM to counting fingers at two feet (CF), was de-
fined as 2 line change in LogMAR vision. Anatomical
success was defined as complete retinal re-attachment
at six months without the need for repeat surgery. Func-
tional success was defined as either preservation of
VA post-operatively at better than ambulatory vision de-
fined as BCVA of 6/120 or better, or improvement of 2
lines in LogMAR vision, after conversion from Snellen
VA. All other post-operative complications were re-
corded. Elevated intraocular pressure (IOP) was defined
as IOP > 25 mmHg.
CMVR was diagnosed clinically based on indirect oph-
thalmoscopy findings of the typical appearance of the
disease. No aqueous or vitreous samples were obtained
for viral PCR to confirm or exclude the diagnosis. The
lesion typically consisted of an area of retinal necrosis
or edema surrounded by granular infiltrates and a
silvery-white border marking the edge of the active bor-
ders, with variable amounts of retinal hemorrhage and
inflammatory vascular sheathing. Angiography was not
performed. All cases of CMVR were diagnosed pre-
operatively. CMVR lesions were described based on le-
sion size and their location. Lesion size was classified
categorically as <25%, 25% to 49%, and >50% based on
accurate clinical drawings. The location of CMVR lesion
in each eye was categorized into three zones as de-
scribed by Holland et al: Zone 1 was defined as the area
within 1500 μm of the optic nerve or within 3000 μm of
the centre of the macula. Zone 2 extended from zone 1
to the vortex veins and zone 3 involved the area anterior
to the vortex veins [4]. For patients with CMVR involv-
ing multiple zones, the zone nearest to the macula was
reported. CMV-related immune recovery uveitis (IRU)
was defined and diagnosed clinically as a syndrome of
anterior segment and vitreous inflammatory reactions
directed towards CMV antigens in ocular tissues in pa-
tients with AIDS, associated with recovery of immuno-
competence as a result of HAART [5]. The chronic
inflammation from IRU is a risk factor for RD.
Intervals between CMVR and RD were expressed in
months. Demographic information, ophthalmic examin-
ation and retinal detachment characteristics such as
the presence of PVR, surgical characteristics includingconcurrent lens removal and CMVR activity were grouped
into categories and analyzed as categorical variables
against anatomical and functional success using Fisher’s
exact test. Continuous variables such as CD4 counts were
analyzed with Mann-Whitney U test when medians were
compared. Data analyses were performed with IBM SPSS
Statistics (Version 19, IBM Corp, New York, USA).
Results
A total of 19 eyes with CMVR-related RD underwent
retinal re-attachment surgery. These constituted 0.48%
of 3996 patients who were diagnosed with HIV from
years 2000-2011 in Singapore. Majority of our patients
were males (84.2%) and of Chinese ethnicity (73.7%).
Median CD4 count at time of diagnosis of RD was 91.5
cells/μL (range 15-571 cells/μL) with a median occur-
rence at 16.5 months (range 3.0-210.0 months) after
HIV diagnosis. The median time from CMVR to RD was
2.7 months (range 0-121 months). Figure 1 shows the
survival curve relating RD occurrence from CMVR on-
set. Eighteen (94.7%) patients were on HAART. Patient
characteristics are summarized in Table 1.
Eighteen patients (94.7%) were treated with intravitreal
ganciclovir upon diagnosis of CMVR with one patient
receiving oral valganciclovir. This treatment was insti-
tuted immediately after the diagnosis of CMVR. Intravit-
real ganciclovir was first given at an induction dose of
2 mg/0.04mls twice a week for 1 month and then main-
tained at 1 mg/0.02mls weekly until CD4 counts were
above 100 cells/μL. CD4 counts were monitored 3 monthly
when it was less than or equal to 500 cells/μL, and 6
monthly if greater than to 500 cells/ μL. Five eyes had active
CMVR at the time of RD while the other eyes had quies-
cent disease after ganciclovir/valganciclovir treatment. The
median CD4 count of patients with active disease at the
time of RD was 67 cells/μL (range 20-247 cells/μL) com-
pared to 93.0 cells/μL (range 15-57 1cells/μL) (p = 0.321)
for patients with inactive CMVR. The characteristics of
CMVR in these patients are summarized in Table 2. Seven
(36.8%) patients had concomitant IRU, all of which oc-
curred prior to RD. The median time from diagnosis of
IRU to RD was 1.0 months (range 0-12 months). The me-
dian CD4 count of the 6 patients who had IRU just prior to
retinal detachment was 154 cells/μL (range 20-333 cells/
μL) compared to 68 cells/μL (range 15-571 cells/μL) in the
patients who did not have IRU (p = 0.840).
The characteristics of the RDs and surgical details are
summarized in Tables 2 and 3 respectively. Ten patients
(52.6%) had a combined vitrectomy and scleral buckle
procedure performed, seven patients (36.8%) underwent
vitrectomy without scleral buckle, and 2 patients had
only scleral buckling with cryopexy performed. Five
patients had removal of silicone oil during the first
6 months after surgery. During follow-up, anatomical
Figure 1 Survival curve - time to RD from CMVR diagnosis.
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patients (26.3%) had repeat detachments during the first
six months of follow-up, two of whom declined further
intervention due to poor prognosis. The anatomical out-
comes at one month, three months and six months
post-surgery are shown in Figure 2. Functional success
was achieved in 10 patients (52.6%) at 3 and 6 months.
At 6 months, 7 patients (36.8%) had improvement of VA
by 2 or more lines, 8 patients (42.1%) retained similar
VA, and three patients (15.8%) had drop of visual acuity
by 2 or more lines. Of the 13 patients who presented
with counting fingers or worse vision, 4 (30.8%) im-
proved to 6/120 or better. Two patients had eventual
BCVA of PL due to silicone oil-related glaucomatous
optic neuropathy and retinal re-detachment respectively.
Both of them declined further surgical intervention.
Three patients had eventual NPL vision- one patient had
repeat RD and declined surgery, the second suffered
from optic atrophy and the third patient developed
phthisis bulbi after retinal re-detachment. The VA out-
comes are shown in Figure 3.
A further subset analysis was performed on patients
who underwent vitrectomy. The outcomes of patients
who underwent 20-gauge versus 23-gauge vitrectomy
were compared. The anatomical success rates at 3 and
6 months of patients who underwent 23-gauge vitrec-
tomy was 88.9% as compared to 62.5% in patients whounderwent 20-gauge vitrectomy. The functional success
rates were 77.8% and 12.5% for 23-gauge and 20-gauge
vitrectomy respectively.
The complications of retinal re-attachment surgery in
our patients are shown in Table 3. The most common
complications were cataract formation, PVR and elevated
IOP. Of the 11 phakic eyes post-RD surgery, six (54.5%)
developed cataracts. The median time to development of
cataract was six months (range 1 - 15 months).
The results of univariate analysis of factors affecting ana-
tomical and functional success are shown in Table 4. Pa-
tients with <50% areas of CMVR showed a trend towards
anatomical success (p = 0.197) and functional success
(p = 0.245). There was also a trend towards anatomical
success (p = 0.201) and functional success (p = 0.09) in
patients who underwent 23-gauge vitrectomy. Active
CMVR at the time of RD was not associated with higher
re-detachment rates (p = 0.570) as compared to inactive
CMV retinitis.
Discussion
Retinal detachments still occur despite successful control
of CMVR with anti-CMV medications. The risk of RD is
increased with CMVR. Gliotic bands found at the border
of normal and CMVR-affected retinae have been postu-
lated to form as a response to inflammatory insult. This
acts as a source of vitreo-retinal traction leading to retinal








HAART use during RD, n (%)
Yes 18 (94.7)
No 1 (5.3)
Intravitreal Ganciclovir use, n (%)
Yes 18 (94.7)
No† 1 (5.3)
IRU before retinal detachment, n (%)
Yes 7 (36.8)
No 12 (63.2)
Mean age, years (SD)




Median CD4 counts, cells/μL [Range]
HIV diagnosis 97.0 [2 - 830]
CMV retinitis diagnosis 53.0 [6 - 410]
Retinal detachment (RD) 91.5 [15 - 571]
Active CMVR at RD (n = 5) 67.0 [20 - 247]
Inactive CMVR at RD (n = 13) 93.0 [15 - 571]
Median intervals, months [Range]
HIV to RD 16.5 [3 - 210]
CMV retinitis to RD 2.7 [0 - 121]
HIV to commencement of HAART 14.6 [0 - 217]
Commencement of HAART to RD 9.0 [-1 - 112]
Immune recovery uveitis to RD 1.0 [0 - 12]
†Received oral valganciclovir.
HAART: highly active anti-retroviral therapy, RD: retinal detachment, IRU:
immune recovery uveitis, HIV: Human immunodeficiency virus, CMVR:
cytomegalovirus retinitis.
Table 2 Characteristics of CMV retinitis and retinal
detachment
n (%)
CMV retinitis zonal involvement
Zone 1 3 (16.7)
Zone 2 10 (55.6)
Zone 3 5 (27.8)
CMV retinitis size
< 25% 8 (44.4)
25 - 49% 6 (33.3)
50 - 74% 3 (16.7)
> = 75% 1 (5.6)
CMV activity at RD
Active 5 (26.3)
Inactive 14 (73.7)









No breaks found 3 (15.8)
Area of retinal defect
CMV retinitis involved retina 15 (78.9)
Normal retina 1 (5.3)
None 3 (15.8)
†3 grade A PVR, 1 grade B/C.
CMV: cytomegalovirus, RD: retinal detachment, PVR: proliferative vitreo-retinopathy.
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cessary to preserve vision and improve the quality of life
in these patients. Favorable treatment results of CMV-
related RDs by vitrectomy and silicone oil injection over
other techniques such as scleral buckling, pneumatic
retinopexy or vitrectomy and fluid gas exchange have
been reported for these complex detachments. Perman-
ent silicone oil tamponade in the vitreous cavity have
been advocated to seal current and future holes should
retinitis progress, and also to provide a clear media for
laser retinopexy. However techniques and preferences
have varied over the years.Anatomical success rates for CMV-related RD are re-
ported to be lower because of the presence of multiple
breaks, difficulty in identifying and sealing breaks within
necrotic retinae, and the posterior location of breaks [7].
The anatomical success and ambulatory vision rates re-
ported in current literature are 70-84% [6-10] and 65-
84% [8,11] respectively, in CMVR-related RD surgery.
This is lower than results of primary rhegmatogenous
RD repair which achieved anatomical success rates of
72-92% [12,13]. Our anatomical and functional success
rates were 73.7% and 52.6% respectively. Although prog-
nosis after surgery for CMV-related RD is poor, up to
half of these patients will regain ambulatory vision which
contribute to overall better function and quality of life.
Factors related to better anatomical outcomes within
our patients include a smaller lesion size (<50%), the use
of 23-gauge vitrectomy systems and the absence of PVR.















Heavy SO 3 (15.8)
Post-op complications
Band keratopathy 2 (10.5)
High IOP > 25 mmHg 4 (21.1)
PVR 4 (21.1)
Optic atrophy (unspecified cause) 2 (10.5)
Cataract (11 phakic eyes after RD surgery) 6 (54.5)
†4 patients left aphakic, 2 had primary IOL implantation.
2 out of 4 aphakic patients underwent secondary IOL implantation, 1 patient
had silicon oil glaucoma and was left aphakic, the other had poor vision and
band keratopathy and declined further surgery.
SO: silicone oil, IOP: intraocular pressure, PVR: proliferative vitreo-retinopathy.
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trectomy systems was also related to better functional
outcome in our patients. The trend towards better out-
comes for patients who underwent 23-gauge vitrectomy
as compared to patients who underwent 20-gauge vitrectomyFigure 2 Anatomical outcomes at one month, three months and six mstrongly suggests that improvement in vitrectomy sys-
tems with time has a positive influence on patient out-
comes. CD4 counts were found to be unrelated to the
surgical outcomes in our patients. Median CD4 count
for patients with active CMVR at the time of RD was
lower than patients with inactive CMVR, consistent
with higher risks of opportunistic infections in patients
with lower CD4 count levels. Untreated CMVR spreads
at an average of 250-350 μm per week [14] and even in
cases where anti-CMV therapy has been commenced,
prior to control of active retinitis, there is still progres-
sion of the disease albeit at a slower rate. It is thus likely
that for patients with active retinitis at the time of sur-
gery, the area of retinitis will continue to spread beyond
areas of retinopexy resulting in new retinal breaks and
recurrent detachments. As such it is prudent to include
several rows of barrier retinopexy in cases of RD repair
in the presence of active retinitis, more so than in standard
cases of retinal breaks in rhegmatogenous RDs. Active
CMVR was however not associated with a clinically higher
risk of re-detachment among our patients.
IRU is a causative factor for PVR, the main risk factor
in failed RDs, due to retinal traction [15]. Irvine et al
reported that the mean times of CMVR to RD was
5.5 months for patients with more than three diopters of
myopia, and 8 months in those with less than 1 diopter of
myopia [16]. Our study revealed that a high proportion of
patients had a short median interval of 2.7 months and
1.0 month between the occurrences of CMVR and IRU to
the development of RD respectively. This suggests that pa-
tients need close monitoring for the development of RD
even after anti-CMV therapy and HAART have been
commenced.
Our results showed that apart from cataract formation
(54.5%), complication rates were generally low. Cataract
incidence after silicone oil tamponade has been reportedonths post-surgery.
Figure 3 Scatterplot of visual acuities at presentation (before surgery) and six months after surgery.
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time of cataract of six months was comparable to the
published rates of four to seven months [8,18,19]. Clear
lens extraction with intraocular lens implantation during
repair of RD or during removal of silicone oil was advo-
cated by Engstrom to improve long term visual rehabili-
tation and decrease morbidity associated with further
surgeries [20]. Although concurrent cataract extraction
during RD repair may allow better anterior vitreous
clearance, we did not routinely perform lens extraction
surgery unless indicated, due to greater post-operative
intraocular inflammation with its attendant complica-
tions in these inflamed eyes, as well as the potential loss
of accommodation in these patients who are frequently
younger than those who present with primary rhegma-
togneous RDs. Almost 30% of our patients were below
40 years old, and lens extraction surgery would have re-
sulted in the loss of accommodation in these patients.
Increased IOP is a common complication after vitrec-
tomy and silicone oil tamponade. A transient ocular
hypertension has been reported to occur in between 12-
70% of cases, and development of glaucoma in up to
40% of cases with complex RDs [21,22]. Our experience
was similar with 21.1% of patients developing a transient
IOP rise after surgery. This was higher than the 7.5% of
patients who had transient IOP rise after surgery in our
audit of patients who underwent surgical reattachmentfor primary rhegmatogenous RDs (unpublished data). Of
the four patients with raised IOP after surgery, only one
required treatment with topical IOP-lowering eyedrops
for more than two months duration. None require glau-
coma filtration surgery. Two patients (10.5%) developed
band keratopathy after surgery, which was reported to
occur in 4-6% of eyes with complex RD [8,13]. Other re-
ported complications include progressive optic atrophy
and possible retinal toxicity due to both CMV infection
and silicone oil toxicity [23].
We acknowledge that there are limitations in our
study. Although this was a retrospective study, all our
patients had at least 6 months of follow-up after initial
surgery. We felt that this was an appropriate and ad-
equate duration for visual rehabilitation, or time for
development of any complications. Six vitreo-retinal sur-
geons were involved in the surgeries for these 19 eyes
and this may lead to a study bias with regards to surgical
outcomes. The operative techniques were however fairly
standard and performed by trained and experienced sur-
geons. Subset analysis for 20 and 23-gauge vitrectomy
was performed to account for changing surgical systems
with time. Singapore is classified by WHO as a low-risk
HIV epidemic country [24] with reasonably good acces-
sibility to anti-CMV therapy and HAART. As such even
though data was collated over 12 years, we had a relatively
small number of patients. However this also reflects
Table 4 Univariate analysis of factors affecting
anatomical success and functional success
Characteristics p-value*
Anatomical success at 6 months vs
CD4 counts at RD 0.915
CMVR activity at surgery 0.570
CMV size </> 50% 0.197
Macula on/off RD > 0.999
Presence of PVR 0.272
Presence of IRU 0.603
Concurrent scleral buckling 0.628
23G/20G vitrectomy 0.201
Functional success at 6 months vs
CD4 counts at RD 0.847
CMV size </> 50% 0.103
CMVR activity at surgery 0.314
CMV macula involvement 0.088
RD size </> 50% 0.321
Macula on/off RD > 0.999
Presence of PVR > 0.999
Presence of IRU 0.367
23G/20G vitrectomy 0.090
RD: retinal detachment, CMVR: cytomegalovirus retinitis,
PVR: proliferative vitreo-retinopathy, IRU: immune recovery uveitis.
*CD4 counts at RD analysed with Mann Whitney test, other variables analysed
with Fisher’s.
Exact test.
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lation locally. This may have affected our analysis as cor-
relation between our outcomes and CMVR and RD
characteristics did not yield statistically significant results
although there was a statistical trend towards a difference.
A study of a larger number of patients may increase the
robustness of statistical analysis. Nonetheless, despite the
smaller number of patients, the participants in this study
were consecutive patients of all RD secondary to CMVR
and had all relevant clinical information obtained, thus we
felt represented a good sample of our population.
Conclusion
AIDS patients with CMVR have a high risk of RD and
surgery for these detachments have a good outcome to
improve vision or preserve ambulatory vision. With ad-
vancements in anti-retroviral therapy, quality-of-life is of
increasing importance to AIDS patients today who have
a much longer life expectancy as compared to AIDS pa-
tients diagnosed with CMVR previously. Retinal re-
attachment surgery for patients with CMVR-related RD
gives them a viable chance of maintaining or improving
their vision, and their quality of life.Competing interests
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